LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 92

Search options

  1. Article ; Online: Thalidomide, the story goes on.

    Papaseit, Esther / Farré, Magí / Garcia-Algar, Óscar

    Anales de pediatria

    2023  Volume 98, Issue 6, Page(s) 490–491

    MeSH term(s) Thalidomide/adverse effects
    Chemical Substances Thalidomide (4Z8R6ORS6L)
    Language English
    Publishing date 2023-05-08
    Publishing country Spain
    Document type Letter
    ZDB-ID 2830901-7
    ISSN 2341-2879 ; 2341-2879
    ISSN (online) 2341-2879
    ISSN 2341-2879
    DOI 10.1016/j.anpede.2023.03.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: La nueva moda de consumo de algunos inhalantes: riesgos y alerta por la falsa inocuidad.

    Cárdenas-Quesada, Jose / Pérez-Mañá, Clara / Papaseit, Esther / Farré, Magí

    Medicina clinica

    2023  Volume 161, Issue 12, Page(s) 543–546

    Title translation The new trend of some inhalant use: Risks and warnings of false harmlessness.
    Language Spanish
    Publishing date 2023-07-28
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1016/j.medcli.2023.07.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Metabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMS.

    Massano, Marta / Nuñez-Montero, Melani / Papaseit, Esther / Hladun, Olga / Pérez-Maña, Clara / Ventura, Mireia / Marchei, Emilia / Alladio, Eugenio / Gerace, Enrico / Pichini, Simona / Farrè, Magi / Salomone, Alberto

    Journal of pharmaceutical and biomedical analysis

    2024  Volume 241, Page(s) 115994

    Abstract: Forensic laboratories are constantly required to identify new drugs and their metabolites. N-ethylhexedrone (NEH, HEXEN), N-Ethylpentedrone (NEP), and 4-Chloromethcathinone (4-CMC, clephedrone) are synthetic substances structurally related to natural ... ...

    Abstract Forensic laboratories are constantly required to identify new drugs and their metabolites. N-ethylhexedrone (NEH, HEXEN), N-Ethylpentedrone (NEP), and 4-Chloromethcathinone (4-CMC, clephedrone) are synthetic substances structurally related to natural cathinone, alkaloid present in the leaves of the Catha edulis (Khat) plant. These synthetic cathinones (SC) are members of the heterogenous family of new psychoactive substances (NPS) that raised major concerns in scientific and forensic communities over the past years due to their widespread consumption. In this context, we investigated their metabolic profile using of UHPLC-QTOF-HRMS to elucidate the distribution of the parent drug and its metabolites in urine samples over time. Initially, both male and female volunteers were divided into three groups and eight subjects of each group were administered intranasally or orally with one SC (20-40 mg of NEH or NEP intranasal, 100-150 mg of 4-CMC oral). Urine samples were collected at 0-2 and 2-4 or 2-5 h. Urine (50 μL) was diluted 1:2 with acetonitrile/methanol (95:5) and injected into the UHPLC-QTOF-HRMS. Phase-I and phase-II metabolites were identified on the basis of fragmentation patterns and exact masses. Several phase-I and glucuronide-phase-II metabolites were identified in urine samples. Keto group reduction, hydroxylation and dealkylation were the common metabolic pathways identified for all cathinones and the presence of NEH-glucuronide, NEP-glucuronide and 4-CMC-glucuronide was also relevant. Significant is the slower metabolite formation for 4-CMC, which was detected at high concentrations in its original form even 5 h after administration, due to its long half-life and low intrinsic clearance compared to the other SCs. UHPLC-QTOF-HRMS demonstrated a considerable capability to semi-quantify the three synthetic cathinones and identify the target metabolites with high reliability. The introduction of new target compounds improves the efficiency of toxicological screening analysis on real samples and extends the window of detection of the SCs in biological matrices.
    MeSH term(s) Humans ; Chromatography, High Pressure Liquid ; Synthetic Cathinone ; Reproducibility of Results ; Glucuronides ; Metabolome ; Methylamines ; Propiophenones
    Chemical Substances clephedrone (PTAYYYZMMT) ; Synthetic Cathinone ; Glucuronides ; Methylamines ; Propiophenones
    Language English
    Publishing date 2024-01-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 604917-5
    ISSN 1873-264X ; 0731-7085
    ISSN (online) 1873-264X
    ISSN 0731-7085
    DOI 10.1016/j.jpba.2024.115994
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: UHPLC-HRMS and GC-MS Screening of a Selection of Synthetic Cannabinoids and Metabolites in Urine of Consumers.

    Pellegrini, Manuela / Marchei, Emilia / Papaseit, Esther / Farré, Magí / Zaami, Simona

    Medicina (Kaunas, Lithuania)

    2020  Volume 56, Issue 8

    Abstract: Background and ... ...

    Abstract Background and Objectives
    MeSH term(s) Chromatography, High Pressure Liquid/methods ; Gas Chromatography-Mass Spectrometry/methods ; Humans ; Illicit Drugs/urine ; Indoles/urine ; Naphthalenes/urine ; Reproducibility of Results
    Chemical Substances (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ; 4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone ; Illicit Drugs ; Indoles ; Naphthalenes ; (4-methyl-1-naphthyl)-(1-pentylindol-3-yl)methanone (44147RI31X)
    Language English
    Publishing date 2020-08-13
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2188113-3
    ISSN 1648-9144 ; 1010-660X
    ISSN (online) 1648-9144
    ISSN 1010-660X
    DOI 10.3390/medicina56080408
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence.

    Mas, Marta / García-Vicente, Juan Antonio / Estrada-Gelonch, Anaïs / Pérez-Mañá, Clara / Papaseit, Esther / Torrens, Marta / Farré, Magí

    Journal of clinical medicine

    2022  Volume 11, Issue 14

    Abstract: The COVID-19 pandemic has encouraged the repurposing of existing drugs as a shorter development strategy in order to support clinicians with this difficult therapeutic dilemma. There is evidence to support the theory that some antidepressants can reduce ... ...

    Abstract The COVID-19 pandemic has encouraged the repurposing of existing drugs as a shorter development strategy in order to support clinicians with this difficult therapeutic dilemma. There is evidence to support the theory that some antidepressants can reduce concentrations of different cytokines in humans and animals and, recently, the antiviral activity of some antidepressants against SARS-CoV-2 has been reported. The aims of this narrative review are to evaluate the possible role of antidepressants in the treatment of COVID-19 infection and the possible benefits and risks of patients taking antidepressants for mental disorders and COVID-19 infection. A review was performed to analyse the current literature to identify the role of antidepressant medication in the treatment of COVID-19 patients. The electronic search was completed in MEDLINE and MedRxiv/BioRxiv for published literature and in ClinicalTrials.gov for ongoing clinical trials. The results show some evidence from preclinical data and observational studies about the possible efficacy of some specific antidepressants for treating COVID-19 infection. In addition, two published phase II studies testing fluvoxamine showed positive results for clinical deterioration and hospitalization rate versus a placebo. Seven ongoing clinical trials testing fluvoxamine, fluoxetine, and tramadol (as per its anti-inflammatory and antidepressant effect) are still in the early phases. Although the available evidence is limited, the sum of the antiviral and anti-inflammatory preclinical studies and the results from several observational studies and two phase II clinical trials provide the basis for ongoing clinical trials evaluating the possible use of antidepressants for COVID-19 infection in humans. Further investigations will be needed to support the possible use of antidepressants for this application.
    Language English
    Publishing date 2022-07-12
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm11144038
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case report.

    Alvarez, Pilar / Papaseit, Esther / Pérez, Víctor / Bulbena, Antoni / Farré, Magí

    Actas espanolas de psiquiatria

    2019  Volume 47, Issue 1, Page(s) 33–36

    MeSH term(s) Antimanic Agents/administration & dosage ; Antimanic Agents/adverse effects ; Antimanic Agents/therapeutic use ; Antipsychotic Agents/administration & dosage ; Antipsychotic Agents/adverse effects ; Antipsychotic Agents/therapeutic use ; Bipolar Disorder/drug therapy ; Drug Therapy, Combination/adverse effects ; Humans ; Male ; Middle Aged ; Olfaction Disorders/chemically induced ; Quetiapine Fumarate/administration & dosage ; Quetiapine Fumarate/adverse effects ; Quetiapine Fumarate/therapeutic use ; Taste Disorders/chemically induced ; Valproic Acid/administration & dosage ; Valproic Acid/adverse effects ; Valproic Acid/therapeutic use
    Chemical Substances Antimanic Agents ; Antipsychotic Agents ; Quetiapine Fumarate (2S3PL1B6UJ) ; Valproic Acid (614OI1Z5WI)
    Language English
    Publishing date 2019-01-01
    Publishing country Spain
    Document type Case Reports ; Letter
    ZDB-ID 1480971-0
    ISSN 1578-2735 ; 1575-071X ; 1139-9287
    ISSN (online) 1578-2735
    ISSN 1575-071X ; 1139-9287
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: GC-MS/MS Determination of Synthetic Cathinones: 4-chloromethcathinone, N-ethyl Pentedrone, and N-ethyl Hexedrone in Oral Fluid and Sweat of Consumers under Controlled Administration: Pilot Study.

    Nuñez-Montero, Melani / Lombroni, Claudia / Maida, Nunzia La / Rotolo, Maria Concetta / Pichini, Simona / Papaseit, Esther / Hladun, Olga / Ventura, Mireia / Poyatos, Lourdes / Pérez-Mañá, Clara / Farré, Magí / Marchei, Emilia

    International journal of molecular sciences

    2023  Volume 24, Issue 11

    Abstract: This study presents a validated GC-MS/MS method for the detection and quantification of 4-chloromethcathinone or clephedrone (4-CMC), N-ethyl Pentedrone (NEP), and N-ethyl Hexedrone (NEH, also named HEXEN) in oral fluid and sweat and verifies its ... ...

    Abstract This study presents a validated GC-MS/MS method for the detection and quantification of 4-chloromethcathinone or clephedrone (4-CMC), N-ethyl Pentedrone (NEP), and N-ethyl Hexedrone (NEH, also named HEXEN) in oral fluid and sweat and verifies its feasibility in determining human oral fluid concentrations and pharmacokinetics following the administration of 100 mg of 4-CMC orally and 30 mg of NEP and NEH intranasally. A total of 48 oral fluid and 12 sweat samples were collected from six consumers. After the addition of 5 μL of methylone-d
    MeSH term(s) Humans ; Tandem Mass Spectrometry/methods ; Synthetic Cathinone ; Gas Chromatography-Mass Spectrometry/methods ; Pilot Projects ; Sweat
    Chemical Substances pentedrone (2ELU1B757Q) ; clephedrone (PTAYYYZMMT) ; ethyl acetate (76845O8NMZ) ; Synthetic Cathinone
    Language English
    Publishing date 2023-05-27
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms24119387
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH.

    Sprega, Giorgia / Di Giorgi, Alessandro / Poyatos, Lourdes / Papaseit, Esther / Pérez-Mañá, Clara / Tini, Anastasio / Pichini, Simona / Busardò, Francesco Paolo / Lo Faro, Alfredo Fabrizio / Farré, Magí

    Metabolites

    2023  Volume 13, Issue 4

    Abstract: The aim of this study was to investigate methylone and its metabolites concentration in oral fluid following controlled increasing doses, focusing on the effect of oral fluid pH. Samples were obtained from a clinical trial where twelve healthy volunteers ...

    Abstract The aim of this study was to investigate methylone and its metabolites concentration in oral fluid following controlled increasing doses, focusing on the effect of oral fluid pH. Samples were obtained from a clinical trial where twelve healthy volunteers participated after ingestion of 50, 100, 150 and 200 mg of methylone. Concentration of methylone and its metabolites 4-hydroxy-3-methoxy-N-methylcathinone (HMMC) and 3,4-methylenedioxycathinone in oral fluid were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Pharmacokinetic parameters were estimated, and the oral fluid-to-plasma ratio (OF/P) at each time interval was calculated and correlated with the oral fluid pH using data from our previous study in plasma. Methylone was detected at all time intervals after each dose; MDC and HMMC were not detectable after the lowest dose. Oral fluid concentrations of methylone ranged between 88.3-503.8, 85.5-5002.3, 182.8-13,201.8 and 214.6-22,684.6 ng/mL following 50, 100, 150 and 200 mg doses, respectively, peaked between 1.5 and 2.0 h, and were followed by a progressive decrease. Oral fluid pH was demonstrated to be affected by methylone administration. Oral fluid is a valid alternative to plasma for methylone determination for clinical and toxicological studies, allowing for a simple, easy and non-invasive sample collection.
    Language English
    Publishing date 2023-03-24
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662251-8
    ISSN 2218-1989
    ISSN 2218-1989
    DOI 10.3390/metabo13040468
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans.

    Di Giorgi, Alessandro / Sprega, Giorgia / Poyatos, Lourdes / Papaseit, Esther / Pérez-Mañá, Clara / Di Trana, Annagiulia / Varì, Maria Rosaria / Busardò, Francesco Paolo / Pichini, Simona / Zaami, Simona / Lo Faro, Alfredo Fabrizio / Farré, Magí

    International journal of molecular sciences

    2023  Volume 24, Issue 8

    Abstract: The aim of this study was to determine the excretion of methylone and its metabolites in sweat following the ingestion of increasing controlled doses of 50, 100, 150 and 200 mg of methylone to twelve healthy volunteers involved in a clinical trial. ... ...

    Abstract The aim of this study was to determine the excretion of methylone and its metabolites in sweat following the ingestion of increasing controlled doses of 50, 100, 150 and 200 mg of methylone to twelve healthy volunteers involved in a clinical trial. Methylone and its metabolites 4-hydroxy-3-methoxy-N-methylcathinone (HMMC) and 3,4-methylenedioxycathinone (MDC) were analyzed in sweat patches by liquid chromatography-tandem mass spectrometry. Methylone and MDC were detected in sweat at 2 h and reached their highest accumulation (C
    MeSH term(s) Humans ; Chromatography, Liquid/methods ; Mass Spectrometry ; Methamphetamine/metabolism ; Sweat/chemistry
    Chemical Substances Methamphetamine (44RAL3456C) ; methylone (L4I4B1R01F)
    Language English
    Publishing date 2023-04-17
    Publishing country Switzerland
    Document type Clinical Study ; Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms24087395
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids.

    Lo Faro, Alfredo Fabrizio / Sprega, Giorgia / Beradinelli, Diletta / Tini, Anstasio / Poyatos, Lourdes / Papaseit, Esther / Berretta, Paolo / Di Giorgi, Alessandro / Farre, Magì / Takaishvili, Nino / Farkas, Tivadar / Busardò, Francesco Paolo / Chankvetadze, Bezhan

    Journal of pharmaceutical and biomedical analysis

    2023  Volume 238, Page(s) 115768

    Abstract: In the present study enantioselective high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods were developed for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its major phase-1 metabolites 4- ... ...

    Abstract In the present study enantioselective high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods were developed for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its major phase-1 metabolites 4-hydroxy-3-methoxyamphetamine (HMA), 4-hydroxy-3-methoxymethamphetamine (HMMA) and 3,4-methylenedioxyamphetamine (MDA) in human plasma, sweat, oral fluid (OF) and urine. The simultaneous separation of all these compounds and their respective enantioseparation was accomplished on two polysaccharide-based chiral columns. The Lux AMP column with a proprietary chiral selector enabled baseline separation of the enantiomers of MDMA, HMA and HMMA while MDA enantiomers could not be separated with this column under the experimental conditions used in this study. The Lux i-Amylose-3 column based on amylose tris(5-chloro-3-methylphenylcarbamate) as chiral selector baseline-separated the enantiomers of MDMA, HMMA and MDA while the enantiomers of HMA could not be separated. Thus, the various samples were analyzed by using both columns alternatively in combinations with acetonitrile containing 25% (v/v) 5 mM ammonium bicarbonate buffer at pH 11.0 as mobile phase. Analysis time was less than 4 min with the Lux AMP column and less than 6 min with the Lux i-Amylose-3 column. Both methods were validated and applied to the enantioselective determination of MDMA and its phase-I metabolites in human biological fluids, and enantioselective metabolism of MDMA was confirmed.
    MeSH term(s) Humans ; N-Methyl-3,4-methylenedioxyamphetamine/metabolism ; Chromatography, High Pressure Liquid ; Tandem Mass Spectrometry ; Chromatography, Liquid ; Stereoisomerism ; Amylose ; Methamphetamine ; 3,4-Methylenedioxyamphetamine
    Chemical Substances N-Methyl-3,4-methylenedioxyamphetamine (KE1SEN21RM) ; atrolactic acid (515-30-0) ; Amylose (9005-82-7) ; Methamphetamine (44RAL3456C) ; 3,4-Methylenedioxyamphetamine (4764-17-4)
    Language English
    Publishing date 2023-10-05
    Publishing country England
    Document type Journal Article
    ZDB-ID 604917-5
    ISSN 1873-264X ; 0731-7085
    ISSN (online) 1873-264X
    ISSN 0731-7085
    DOI 10.1016/j.jpba.2023.115768
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top